STAT+: FDA gives Covid vaccine manufacturers instructions for next fall’s shot
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to update their vaccines.

This article has been updated.
The Food and Drug Administration gave Covid vaccine manufacturers instructions on what next fall’s Covid vaccines should target on Thursday, signaling it would prefer that they update the strain in their vaccine to a version of the virus that is currently circulating broadly, LP.8.1.
The statement appeared to leave the door open for Novavax, which uses a vaccine production method that requires months of lead time, to stick with an older version of the virus — an option the company indicated it would prefer to do during a meeting earlier in the day of the FDA’s expert vaccines panel.